FDA limits J&J COVID-19 vaccine due to rare blood clot risk
(WASHINGTON) -- The Food and Drug Administration has put limits on the Johnson & Johnson COVID-19 vaccine due to the rare risk of blood clots."Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18... Read More.